SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-078287
Filing Date
2024-09-13
Accepted
2024-09-13 08:30:09
Documents
13
Period of Report
2024-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0214419-8k_citius.htm   iXBRL 8-K 25540
  Complete submission text file 0001213900-24-078287.txt   200161

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ctor-20240909.xsd EX-101.SCH 3018
3 XBRL LABEL FILE ctor-20240909_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ctor-20240909_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0214419-8k_citius_htm.xml XML 3770
Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Filer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41534 | Film No.: 241296505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)